EQT Options Positioning Flips Bullish Before Q3 Numbers

EQT closed at $55.63 on Friday, up 9.5% over the past month, as the company prepares to report third-quarter results on October 27.

The most notable shift since the October 20 preview print is in options. The put/call ratio has dropped to 1.05, nearly 1.4 standard deviations below its 20-day average of 1.16. That's a meaningful reversal from mid-October, when the PCR was running above 1.29. Options traders have rotated away from downside protection into the release, a noticeably less defensive posture than was visible a week ago. The 52-week PCR range runs from 0.47 to 1.53, so the current reading is closer to the neutral midpoint than to either extreme, but the direction of travel matters.

Short interest offers no real counterweight to that picture. At 3.8% of free float, the short position is modest and has risen about 13% over the past month in share terms, but borrow conditions remain exceptionally loose: availability is running above 2,100%, meaning there are more than twenty shares available to lend for every one already borrowed. Cost to borrow is just 0.39%. Nothing in the lending market points to conviction behind the short side.

The analyst debate is unchanged from before the October 20 pre-announcement. Targets have been quietly trimmed: UBS, Mizuho, and Jefferies all cut in the weeks leading up to the earlier print, and Scotiabank's new Sector Perform initiation at $54 sits almost exactly at Friday's close. The consensus mean is $66.54, implying roughly 20% upside. That gap is the core tension. Bears point to net debt still at $5.5 billion at mid-year, above the $5 billion year-end target management has flagged, and to basis weakness with the TETCO-M2 differential widening to negative $0.85. The Q2 CFPS estimate was cut 10% to $1.56. Bulls counter with a 15% capex beat in Q2, a 3% production guidance raise, and the longer-term demand argument: data center growth, a 10-year gas supply agreement, and an LNG offtake deal that position EQT to benefit from tightening in-basin pricing.

On the week, EQT's 2.4% gain trailed the median of its closest peers. RRC rose 5.9% and AR gained 7.1% over the same period, while EXE and CNX added 2.4% and 3.2% respectively. EQT lagged all of them. Whether that gap reflects lingering basis-weakness concern or simply relative positioning ahead of its own print is what the October 27 release will clarify, specifically whether the Q3 production and free cash flow numbers justify the current price relative to peers that have moved faster.